Published in Nat Clin Pract Nephrol on May 01, 2007
Complement and the atypical hemolytic uremic syndrome in children. Pediatr Nephrol (2008) 1.99
Tissue-specific deletion of Crry from mouse proximal tubular epithelial cells increases susceptibility to renal ischemia-reperfusion injury. Kidney Int (2014) 1.44
Progress and Trends in Complement Therapeutics. Adv Exp Med Biol (2013) 1.20
Complement in glomerular injury. Semin Immunopathol (2007) 0.99
Current status and issues of C1q nephropathy. Clin Exp Nephrol (2009) 0.94
Differential Ly6C Expression after Renal Ischemia-Reperfusion Identifies Unique Macrophage Populations. J Am Soc Nephrol (2015) 0.87
Diverse clinical and histology presentation in c1q nephropathy. Nephrourol Mon (2013) 0.86
Discovering hidden relationships between renal diseases and regulated genes through 3D network visualizations. BMC Res Notes (2010) 0.85
Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol (2009) 0.84
C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway. PLoS One (2014) 0.79
Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pH. Front Immunol (2015) 0.79
Anticomplement therapy. Biologics (2008) 0.76
C1q nephropathy- unity in diversity. J Renal Inj Prev (2013) 0.75
Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant (2007) 4.99
Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med (2002) 3.39
Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med (2006) 1.97
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J Clin Invest (2008) 1.94
Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med (2003) 1.92
Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol (2006) 1.87
C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol (2009) 1.85
Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction. Kidney Int (2010) 1.83
Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype. J Immunol (2006) 1.57
Paranoid psychosis and myoclonus: flecainide toxicity in renal failure. Cardiology (2008) 1.48
Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury. J Clin Invest (2016) 1.43
Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J (2006) 1.38
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood (2007) 1.37
Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood (2008) 1.33
Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol (2007) 1.27
Dendritic cell function in allostimulation is modulated by C5aR signaling. J Immunol (2009) 1.24
Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol (2011) 1.24
The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm Allergy Drug Targets (2009) 1.22
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. Blood (2005) 1.19
Homeostatic proliferation of lymphocytes results in augmented memory-like function and accelerated allograft rejection. J Immunol (2008) 1.17
TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol (2006) 1.12
Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J (2007) 1.11
Inhibition of TLR2 promotes graft function in a murine model of renal transplant ischemia-reperfusion injury. FASEB J (2011) 1.08
Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. J Am Soc Nephrol (2006) 1.08
Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS. Mol Immunol (2011) 1.06
Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol (2006) 1.06
C3a and C5a promote renal ischemia-reperfusion injury. J Am Soc Nephrol (2012) 1.05
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract (2008) 1.03
The use of eculizumab in renal transplantation. Clin Transplant (2013) 1.00
The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol (2007) 1.00
CD59a deficiency exacerbates ischemia-reperfusion injury in mice. Am J Pathol (2004) 0.98
Functional modulation of human monocytes derived DCs by anaphylatoxins C3a and C5a. Immunobiology (2011) 0.97
Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol (2003) 0.97
Illness trajectories: an important concept in the management of kidney failure. Nephrol Dial Transplant (2008) 0.97
Expression of complement components, receptors and regulators by human dendritic cells. Mol Immunol (2011) 0.96
CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J Immunol (2006) 0.95
Controlling the generation and function of human CD8+ memory T cells in vitro with immunosuppressants. Transplantation (2006) 0.94
Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response. J Am Soc Nephrol (2004) 0.94
Minireview: functions of the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int (2004) 0.92
Ultra-localization of Foxp3+ T cells within renal allografts shows infiltration of tubules mimicking rejection. Am J Pathol (2007) 0.92
Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch. Transplantation (2003) 0.92
Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. FASEB J (2008) 0.91
Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cells. BMC Microbiol (2009) 0.91
The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli. Mol Immunol (2007) 0.90
Role of dendritic cell synthesis of complement in the allospecific T cell response. Mol Immunol (2006) 0.90
Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury. Am J Pathol (2004) 0.89
Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab. Transplantation (2011) 0.89
Deficiency of C5aR prolongs renal allograft survival. J Am Soc Nephrol (2010) 0.88
Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells. Am J Pathol (2010) 0.88
Rapamycin at subimmunosuppressive levels inhibits mesangial cell proliferation and extracellular matrix production. Am J Physiol Renal Physiol (2006) 0.88
Tertiary lymphoid organs in renal allografts can be associated with donor-specific tolerance rather than rejection. Eur J Immunol (2010) 0.87
Mechanisms of rejection: role of complement. Curr Opin Organ Transplant (2014) 0.86
Prognosis and management of chronic kidney disease (CKD) at the end of life. Postgrad Med J (2013) 0.85
Which pathways trigger the role of complement in ischaemia/reperfusion injury? Front Immunol (2012) 0.83
RNA interference--a new experimental and therapeutic tool. Curr Opin Nephrol Hypertens (2005) 0.79
Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int (2002) 0.79
Anticoagulation and kidney injury: rare observation or common problem? J Nephrol (2013) 0.79
The innate immune system and transplantation. Cold Spring Harb Perspect Med (2013) 0.79
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis. Am J Kidney Dis (2005) 0.78
Role of complement in tubulointerstitial injury from proteinuria. Kidney Blood Press Res (2002) 0.78
Biomarkers of acute injury: predicting the long-term outcome after transplantation. Kidney Int (2013) 0.78
Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3. J Am Soc Nephrol (2006) 0.77
Control of innate immunological mechanisms as a route to drug minimization. Curr Opin Organ Transplant (2014) 0.77
The role of complement and Toll-like receptors in organ transplantation. Transpl Int (2007) 0.77
C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage. PLoS One (2013) 0.77
Donor specific transplant tolerance is dependent on complement receptors. Transpl Int (2012) 0.76
Granulomatosis with polyangiitis presenting as ischaemic stroke. JRSM Short Rep (2012) 0.75
Should complement activation be a target for therapy in renal transplantation? J Am Soc Nephrol (2008) 0.75
A novel role for nephrin in the maintenance of glomerular structure. J Am Soc Nephrol (2009) 0.75
Footprints of humoral rejection. Curr Opin Nephrol Hypertens (2002) 0.75